Revenue
2020
2021
2022
2023
2024
2025
Ensysce Biosciences, Inc. (ENSC)
Price$0.4557Cached quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2025
Total cash / debt
CashTotal debt
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1M | $5.2M | $2.2M | $2.5M | $3.5M | $3.9M | — | — |
| Research & development | $10.4M | $7.2M | $7.6M | $19.8M | $4.7M | $4.4M | — | — |
| Operating expenses | $15.3M | $11.9M | $12.9M | $26.7M | $23.4M | $5.5M | $3.3M | $1.6M |
| Operating income | −$10.2M | −$6.7M | −$10.7M | −$24.2M | −$19.9M | −$1.6M | −$3.3M | −$959,240 |
| Operating margin | −202.12% | −129.18% | −480.52% | −959.91% | −562.71% | −41.04% | — | — |
| EBITDA | −$10.2M | −$6.7M | −$10.7M | −$24.2M | −$19.9M | −$1.6M | — | — |
| EBITDA margin | −202.00% | −129.18% | −480.52% | −959.91% | −562.71% | −41.03% | — | — |
| Net income | −$10.2M | −$8.0M | −$10.6M | −$24.2M | −$29.1M | $4.3M | −$1.1M | $2.1M |
| Net profit margin | −200.85% | −153.30% | −476.40% | −959.33% | −825.38% | 109.66% | — | — |
| Basic EPSper basic share | -$3.98 | -$11.45 | -$70.40 | -$2,091.30 | -$5,335.20 | $0.00 | -$176,904.00 | -$58,968.00 |
| Diluted EPSper diluted share | -$3.98 | -$11.45 | -$70.40 | -$2,091.30 | -$415,584.00 | $0.00 | -$176,904.00 | -$58,968.00 |
Owners
Reported shareholders
1.29%of listed shares
JANE STREET GROUP, LLC208.83K shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
JANE STREET GROUP, LLC | 1.29%208.83K shares |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.92%149.71K shares |
Virtu Financial LLC | 0.59%95.39K shares |
PERCEPTIVE ADVISORS LLC | 0.53%86.67K shares |
CITADEL ADVISORS LLC | 0.53%86.19K shares |
XTX Topco Ltd | 0.47%77.01K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.38%62.19K shares |
HRT FINANCIAL LP | 0.34%54.43K shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.21%34.28K shares |
TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 0.08%13K shares |
TWO SIGMA SECURITIES, LLC | 0.08%12.95K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.08%12.85K shares |
Tower Research Capital LLC (TRC) | 0.04%6.09K shares |
FNY Investment Advisers, LLC | 0.02%3K shares |
BARCLAYS PLC | <0.01%1.44K shares |
SBI Securities Co., Ltd. | <0.01%641 shares |
BlackRock, Inc. | <0.01%65 shares |
Clear Street Group Inc. | <0.01%1 shares |
Percentages use 16.23M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data